AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 82 filers reported holding AGILE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $42,000 | -88.8% | 31,320 | -82.7% | 0.00% | – |
| Q1 2021 | $376,000 | -24.0% | 180,661 | +4.8% | 0.00% | – |
| Q4 2020 | $495,000 | -5.5% | 172,305 | 0.0% | 0.00% | – |
| Q3 2020 | $524,000 | +6.1% | 172,305 | -3.0% | 0.00% | – |
| Q2 2020 | $494,000 | +1022.7% | 177,672 | +1219.8% | 0.00% | – |
| Q1 2017 | $44,000 | -42.9% | 13,462 | 0.0% | 0.00% | – |
| Q4 2016 | $77,000 | -18.1% | 13,462 | 0.0% | 0.00% | – |
| Q3 2016 | $94,000 | -8.7% | 13,462 | 0.0% | 0.00% | – |
| Q2 2016 | $103,000 | +22.6% | 13,462 | 0.0% | 0.00% | – |
| Q1 2016 | $84,000 | -36.4% | 13,462 | 0.0% | 0.00% | – |
| Q4 2015 | $132,000 | +45.1% | 13,462 | 0.0% | 0.00% | – |
| Q3 2015 | $91,000 | -21.6% | 13,462 | 0.0% | 0.00% | – |
| Q2 2015 | $116,000 | – | 13,462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |